samedan logo
 
 
 
spacer
home > pmps > summer 2003 > the clock ticks for industry compliance on new blister pack standard
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

the Clock Ticks for Industry Compliance on New Blister Pack Standard

Before the end of this year, government legislation will require certain medicines consumed in the UK to comply with a new child-resistant standard. To manufacturers, the implications of this are considerable, not least the potential impact on their production line throughput. However becoming compliant need not be such a headache.

BS8404 is the new child-resistant (CR) standard for blister and strip packs, currently being fast-tracked to legislation by the UK Government and the Medicines and Healthcare Products Regulatory Agency (MHRA). It is expected to become effective as of October 2003, when packs containing aspirin, paracetamol and iron will be required to comply with the new standard. In market terms, this amounts to a total of around 800 million blister packs a year.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jonathan Bobbett, Managing Director of Pill protect™

Jonathan Bobbett is the Owner and Managing Director of Pill protect™ which is part of Three Point Blue Ltd which Jonathan has run for over 15 years.

In addition to Pill protect™, Three Point Blue Ltd offers a range of established creative communication services including branding, graphic design, print management and online system development.

spacer
Jonathan Bobbett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ROUSSELOT INTRODUCES X-PURE® GelMA FOR TRANSLATIONAL MEDICINE

Irving, United States [03 June 2020] — Rousselot, a Darling Ingredients brand and the global leader of collagen-based solutions, takes on the digital challenge and introduces X-Pure® GelMA at Bio Digital 2020. The first GMP-ready range of gelatin methacryloyl (GelMA) biomaterials suitable for preclinical and clinical applications, X-Pure® GelMA is part of the X-Pure portfolio of ultra-pure gelatins and collagens, suitable for use as biomaterials in 3D bioprinting, tissue engineering, and regenerative medicine.
More info >>

White Papers

Transforming Temperature Data Management Practices to Reduce Labor Costs and Improve Visibility and Control

Berlinger & Co AG

There are a number of temperature monitoring database options available to the biopharma supply chain professional and choosing the right one can significantly improve workflow which will reduce administrative time. This article will provide insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. Additionally, it describes the unique features and benefits of the Berlinger Smartview® data management system. Smartview® is a “Software as a Service” (SaaS) platform designed to efficiently and accurately manage both workflow and data in a regulatory compliant manner (21 CRF Part 11 & Annex 11). This comprehensive temperature data management system ensures reliability, accuracy, security, accessibility, and visibility to supply chain professionals, enhancing Good Distribution Practices (GDP) of temperature sensitive shipments.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement